These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15787956)

  • 1. Drug insurance utilization management policies and "reference pricing": an illustrated commentary on the article by Vittorio Maio and colleagues.
    Maclure M
    Milbank Q; 2005; 83(1):131-47. PubMed ID: 15787956
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacy utilization and the Medicare Modernization Act.
    Maio V; Pizzi L; Roumm AR; Clarke J; Goldfarb NI; Nash DB; Chess D
    Milbank Q; 2005; 83(1):101-30. PubMed ID: 15787955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare program; establishment of the Medicare advantage program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4587-741. PubMed ID: 15678604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare prescription drug legislation: how would it affect beneficiaries?
    Moon M
    Policy Brief Commonw Fund; 2003 Oct; (678):1-12. PubMed ID: 14524369
    [No Abstract]   [Full Text] [Related]  

  • 6. The beginning of the end of Medicare.
    Mason DJ
    Am J Nurs; 2004 Jan; 104(1):11. PubMed ID: 14707808
    [No Abstract]   [Full Text] [Related]  

  • 7. Caught in between: prescription drug coverage of Medicare beneficiaries near poverty.
    Shea DG; Stuart BC; Briesacher B
    Issue Brief (Commonw Fund); 2003 Aug; (669):1-8. PubMed ID: 12926411
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicare Part D--the product of a broken process.
    Slaughter LM
    N Engl J Med; 2006 Jun; 354(22):2314-5. PubMed ID: 16738267
    [No Abstract]   [Full Text] [Related]  

  • 9. Prescription drug access: the ANA adopts principles to evaluate congressional Medicare proposals.
    McKeon E
    Am J Nurs; 2003 Sep; 103(9):106. PubMed ID: 14501485
    [No Abstract]   [Full Text] [Related]  

  • 10. A bitter pill: the new Medicare prescription drug benefit.
    Siegel S
    Health Care Law Mon; 2005 Mar; ():3-9. PubMed ID: 15818780
    [No Abstract]   [Full Text] [Related]  

  • 11. Access to Medicare Part D gap coverage more scarce in 2007.
    Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
    [No Abstract]   [Full Text] [Related]  

  • 12. Dramatic improvement or death spiral--two members of congress assess the Medicare bill.
    Kennedy EM; Thomas B
    N Engl J Med; 2004 Feb; 350(8):747-51. PubMed ID: 14973220
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription-drug coverage for medicare beneficiaries.
    Iglehart JK
    N Engl J Med; 2003 Sep; 349(10):923-5. PubMed ID: 12954738
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlling spending for prescription drugs.
    Altman SH; Parks-Thomas C
    N Engl J Med; 2002 Mar; 346(11):855-6. PubMed ID: 11893800
    [No Abstract]   [Full Text] [Related]  

  • 15. The Medicare drug card.
    Stoker J
    Home Healthc Nurse; 2005 Jun; 23(6):364-5. PubMed ID: 15956854
    [No Abstract]   [Full Text] [Related]  

  • 16. What are fairness and consistency in a national pharmacy benefit?
    Daniels N; Sabin JE
    Med Care; 2001 Apr; 39(4):312-4. PubMed ID: 11329518
    [No Abstract]   [Full Text] [Related]  

  • 17. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Emmer S; Allendorf L
    J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare and prescription drugs.
    Iglehart JK
    N Engl J Med; 2001 Mar; 344(13):1010-5. PubMed ID: 11274630
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnesses.
    Donohue JM
    Psychiatr Serv; 2005 Jun; 56(6):645-7. PubMed ID: 15939937
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic conditions and disabilities: trends and issues for private drug plans.
    Boccuti C; Moon M; Dowling K
    Policy Brief Commonw Fund; 2003 Oct; (680):1-10. PubMed ID: 14562797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.